These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33289700)

  • 1. SNRPB-mediated RNA splicing drives tumor cell proliferation and stemness in hepatocellular carcinoma.
    Zhan YT; Li L; Zeng TT; Zhou NN; Guan XY; Li Y
    Aging (Albany NY); 2020 Dec; 13(1):537-554. PubMed ID: 33289700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc-mediated SNRPB upregulation functions as an oncogene in hepatocellular carcinoma.
    Peng N; Li J; He J; Shi X; Huang H; Mo Y; Ye H; Wu G; Wu F; Xiang B; Zhong J; Li L; Zhu S
    Cell Biol Int; 2020 May; 44(5):1103-1111. PubMed ID: 31930637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNRPB promotes the progression of hepatocellular carcinoma via regulating cell cycle, oxidative stress, and ferroptosis.
    Wang X; Zhang H; Guo Z; Wang J; Lu C; Wang J; Jin R; Mo Z
    Aging (Albany NY); 2024 Jan; 16(1):348-366. PubMed ID: 38189879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulatory effect of small nuclear ribonucleoprotein-associated protein B on proliferation and metastasis of liver cancer cells].
    Li YR; Guo D; Chen DF; Lu GF; Ren MD; He SX
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jan; 30(1):63-68. PubMed ID: 35152671
    [No Abstract]   [Full Text] [Related]  

  • 7. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNRPB promotes cervical cancer progression through repressing p53 expression.
    Zhu L; Zhang X; Sun Z
    Biomed Pharmacother; 2020 May; 125():109948. PubMed ID: 32106364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-26b-5p helps in EpCAM+cancer stem cells maintenance via HSC71/HSPA8 and augments malignant features in HCC.
    Khosla R; Hemati H; Rastogi A; Ramakrishna G; Sarin SK; Trehanpati N
    Liver Int; 2019 Sep; 39(9):1692-1703. PubMed ID: 31276277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition.
    Li PD; Chen P; Peng X; Ma C; Zhang WJ; Dai XF
    Aging (Albany NY); 2018 Jan; 10(1):115-130. PubMed ID: 29348394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Chen Y; Yang S; Hu J; Yu C; He M; Cai Z
    PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.
    Qiu H; Zhang X; Ni W; Shi W; Fan H; Xu J; Chen Y; Ni R; Tao T
    Dig Dis Sci; 2016 Mar; 61(3):795-805. PubMed ID: 26553251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma.
    Yang W; Wang C; Lin Y; Liu Q; Yu LX; Tang L; Yan HX; Fu J; Chen Y; Zhang HL; Tang L; Zheng LY; He YQ; Li YQ; Wu FQ; Zou SS; Li Z; Wu MC; Feng GS; Wang HY
    J Hepatol; 2012 Sep; 57(3):613-20. PubMed ID: 22612999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
    Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
    Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secreted protein acidic and rich in cysteine promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells and acquisition of cancerstem cell phenotypes.
    Jiang X; Liu F; Wang Y; Gao J
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1860-1868. PubMed ID: 31041810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM
    Karagonlar ZF; Akbari S; Karabicici M; Sahin E; Avci ST; Ersoy N; Ates KE; Balli T; Karacicek B; Kaplan KN; Celiker C; Atabey N; Erdal E
    Cells; 2020 May; 9(5):. PubMed ID: 32408542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.